Biofarma Group

What Biofarma Group does

Biofarma Group is an Italian-headquartered Contract Development and Manufacturing Organization (CDMO) that produces health nutrition products (nutraceuticals including probiotics and vitamins), medical devices, and active cosmetics for third-party brands. The group operates as Biofarma Srl, registered in Italy with its headquarters in Mereto di Tomba and additional manufacturing sites in Gallarate and San Pietro Viminario (Italy), Biofarma Group France, and following the 2023 acquisition of US Pharma Lab, operations in the United States and China. Biofarma delivers an integrated service stack spanning research and development, quality control laboratory, regulatory advice, contract production, packaging, logistics, and certification, enabling customers to source end-to-end development and manufacturing from a single partner. The company also generates revenue through out-licensing of proprietary products and technologies, including a patented electrospinning-based cosmetic patch platform and an advanced analytical method for lactose detection in food supplements and pharmaceutical products.

The company's revenue model is fundamentally B2B: long-term contract development and manufacturing engagements with enterprise customers in the nutraceutical, medical device, and cosmetics industries, supplemented by licensing royalties on proprietary out-licensed products. Pricing is not publicly disclosed and is quoted on a project basis. Go-to-market is enterprise field sales supported by participation in major industry trade shows (CPHI, SupplySide Global, Healthplex Expo, Nutriform Business Days) and content marketing through the 'Shaping the Future' corporate magazine. Biofarma is owned by private equity firm Ardian following a 2023 transaction that also involved the US Pharma Lab acquisition and reinvestment by current shareholders, making it a privately held, PE-backed industrial CDMO with no public listing.

Name

Biofarma Group

Legal name

Biofarma Srl

Website

https://biofarmagroup.it

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Biofarma Group is an Italian-headquartered CDMO producing nutraceuticals, medical devices, and active cosmetics for third-party brands across Italy, France, the US, and China, operating under private equity owner Ardian since 2023.

Ownership category

akta.pro rank

Product category

Contract Manufacturing Services (CDMO)

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Medical Equipment and Supplies Manufacturing (33911), Scientific Research and Development Services (5417), Packaging and Labeling Services (561910)

SIC

Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

Keywords

• Contract manufacturing services
• Nutraceutical CDMO
• Medical device manufacturing
• Active cosmetics production
• Dietary supplement development

Headquarters

HQ city

Mereto Di Tomba

HQ country

Italy

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: Biofarma Group provides customized development and production of nutraceuticals (including probiotics and vitamins), medical devices, and active cosmetics for third-party companies. Revenue is generated through long-term B2B manufacturing contracts as a CDMO.
2. Out-Licensing Production: The company also engages in out-licensing of proprietary products and technologies, generating additional revenue streams through licensing arrangements.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Biofarma Group is a Contract Development and Manufacturing Organization (CDMO) that produces, develops, and packages health nutrition products (nutraceuticals including probiotics and vitamins), medical devices, and active cosmetics for third-party brands. The company delivers integrated end-to-end services spanning R&D, quality control, regulatory advice, production, packaging, and logistics to enterprise customers across Europe, North America, and Asia.

Product overview

Biofarma Group operates as a Contract Development and Manufacturing Organization (CDMO) providing integrated manufacturing services for the nutraceutical, medical device, and cosmetic industries. The company's product portfolio consists of three main product lines: Health Nutrition (nutraceuticals including probiotics and vitamins), Medical Devices (ready-to-market devices), and Active Cosmetics. These products are supported by a comprehensive suite of services including Research & Development, Quality Control Laboratory, Regulatory Advice, Production, Packaging, and Logistics. Following the acquisition of US Pharma Lab in 2023, the group now operates manufacturing sites across Italy, France, the US, and China, establishing the world's first dedicated toll manufacturer in the nutraceutical industry.

Differentiator

Problem solved

Functional benefit

Products and services

• Health Nutrition Contract manufacturing of health nutrition products for third parties, including nutraceuticals such as probiotics and vitamins, capable of preventing chronic diseases and improving health status.
• Medical Devices Development and manufacturing of innovative, ready-to-market medical devices for third parties and out-licensing arrangements.
• Active Cosmetics Development and production of active cosmetic products for third parties, promoting environmental sustainability and new beauty concepts, including electrospinning-based skincare patches.
• Research & Development Services R&D laboratory services supporting product innovation and development for third-party nutraceutical, medical device, and cosmetics clients.
• Quality Control Laboratory Services Analytical and quality control laboratory services ensuring maximum quality, safety, and regulatory compliance for supplements and pharmaceutical products, including advanced lactose detection methods.
• Regulatory Advice Services Regulatory consulting and advisory services ensuring products comply with applicable regulations across target markets.
• Contract Production Services Contract manufacturing and production services for nutraceutical, medical device, and cosmetic products across facilities in Italy, France, the US, and China.
• Packaging Services Primary and secondary packaging services for nutraceutical, medical device, and cosmetic products.
• Logistics Services Distribution and logistics services for finished products manufactured under contract.
• Certification, Licenses and Policies Services Certification and licensing services ensuring compliance with industry standards and regulations for client products.

Quantifiable outcome

• First dedicated toll manufacturer in nutraceutical industry
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered minor and core.

• AIRC (Associazione Italiana per la Ricerca sul Cancro)minorStrategic or Co-development Partner · 1 January 2025Biofarma Group partners with AIRC in the fight against cancer, firmly supporting the Azalea Research Campaign. The company reaffirms its commitment as a 'Company Against Cancer,' with prevention as a daily choice and research as a promise for the future.
• US Pharma LabcoreStrategic or Co-development Partner · 18 May 2023Biofarma Group acquired 100% of US Pharma Lab, an American company specializing in customized development and production of nutraceuticals including probiotics and vitamins. This acquisition creates the world's first contract manufacturing organization dedicated solely to nutraceutical products with operations in the US, Europe, and China. The deal involved reinvestment by current shareholders.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Aenova Group: German-headquartered CDMO serving pharmaceutical and nutraceutical customers across multiple dosage forms. Most directly comparable to Biofarma as a European mid-market CDMO with a similar mix of contract manufacturing for pharma and consumer health brands.
• Recipharm: Swedish CDMO with multiple European manufacturing sites and PE ownership (EQT), comparable to Biofarma in scale, multi-site European footprint, and contract manufacturing for pharma and consumer health customers.
• NextPharma: European CDMO with sites across the UK, Germany, and Finland providing contract development and manufacturing for pharmaceutical and nutraceutical customers. Closely comparable in service mix (development, manufacturing, packaging) and customer segments.
• Alcami Corporation: US-headquartered CDMO offering contract development, manufacturing, and analytical services to pharma and consumer health clients. Comparable mid-market CDMO profile and service offering, though with US rather than European manufacturing base.
• Adare Pharma Solutions: US CDMO specializing in oral dose formulation and contract manufacturing for pharma and consumer health customers. Comparable in CDMO model and customer types, though with stronger US-centric exposure than Biofarma.

Broad incumbents

• Catalent: Large global pharma CDMO with broad capabilities across biologics, softgel, and oral dose manufacturing. Comparable in CDMO model and enterprise customer base but materially larger and broader in scope than Biofarma's nutraceutical focus.
• Lonza Group: Swiss-listed global CDMO leader serving pharma, biotech, and consumer health customers. Comparable as a contract manufacturing peer but operates at significantly larger scale and with greater biologics exposure than Biofarma.
• Thermo Fisher Scientific (Patheon): Diversified life sciences giant whose Patheon CDMO unit serves global pharma customers with contract manufacturing. Comparable as a CDMO peer but operates as part of a much larger platform with substantially broader capabilities than Biofarma.

Regional players

• Eurofarma: Latin American pharmaceutical company with vertically integrated manufacturing and CDMO activities. Comparable as a regional pharma/nutraceutical manufacturer but serves a different geography than Biofarma's Europe-US-China footprint.

Others

• dsm-firmenich: Global ingredients supplier for nutrition, health, and personal care with adjacent CDMO and contract manufacturing services. Comparable in serving nutrition and cosmetics customers but positioned upstream as an ingredient supplier rather than downstream contract manufacturer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/biofarma-spa
• Instagraminstagram.com/biofarmagroup

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biofarma Group